Novo Nordisk to Cut US Insulin Prices

Novo Nordisk to Cut US Insulin Prices
Image credit: npr

The Facts

  • Previously, some US states instituted price caps on insulin, and the Inflation Reduction Act, which was signed into law last year, mandated that Medicare patients pay no more than $35 a month for insulin.
  • Pres. Joe Biden has called on Congress to pass legislation capping the monthly price of insulin for all Americans at $35.
  • A 2020 study reported that the price of insulin in the US increased by more than $200 from 2007-2018.

Sources Split


The Spin


Narrative A

Novo Nordisk wants to do right by its customers. It’s taken some time to formulate a plan that makes insulin more affordable for patients and keeps the company competitive while it deals with changes in US laws. Diabetes patients can rest assured Novo Nordisk’s insulin products will always be affordable.

Narrative B

Novo Nordisk’s decision is a major win for insulin uses, but there are still plenty of price reductions that need to be made. It’s inexcusable that the US is an outlier when it comes to the high cost of insulin, and it’s time for Sanofi, another major insulin maker, to follow suit and reduce its prices.

© 2026 Improve the News Foundation. All rights reserved.Version 7.17.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 7.17.0